NCT05834348 2025-03-30
DELINOR
Pfizer
Completed
Clinical Trials
4 trialsNCT02679170 2024-08-09
Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)
Pfizer
Completed
NCT04647110 2023-04-06
Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.
Pfizer
Completed
NCT01597258 2019-09-13
Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)
Pfizer
Completed